このページの翻訳は実験的なもので、現在開発中です。お待ちしております

McKesson 将来の成長

Future 基準チェック /26

McKesson利益と収益がそれぞれ年間9.6%と8.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に208.5% 13.1%なると予測されています。

主要情報

10.0%

収益成長率

13.5%

EPS成長率

Healthcare 収益成長	19.3%
収益成長率	8.2%
将来の株主資本利益率	247.5%
アナリストカバレッジ	Good
最終更新日	25 Sep 2024

今後の成長に関する最新情報

更新なし

Recent updates

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

Sep 19

McKesson to acquire Rx Savings Solutions in $875M deal

Sep 19

業績と収益の成長予測

NYSE:MCK - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	411,609	4,366	5,648	6,404	11
3/31/2026	382,814	4,010	4,878	5,867	15
3/31/2025	351,802	3,748	4,980	5,759	14
6/30/2024	313,751	2,959	3,256	3,986	N/A
3/31/2024	308,951	3,002	3,627	4,314	N/A
12/31/2023	301,506	2,998	2,892	3,492	N/A
9/30/2023	291,098	3,487	4,306	4,906	N/A
6/30/2023	284,040	3,755	4,466	5,048	N/A
3/31/2023	276,711	3,563	4,601	5,159	N/A
12/31/2022	273,903	3,146	4,190	4,721	N/A
9/30/2022	272,027	2,061	3,952	4,430	N/A
6/30/2022	268,446	1,396	4,639	5,115	N/A
3/31/2022	263,966	1,119	3,899	4,434	N/A
12/31/2021	257,006	1,415	4,323	4,917	N/A
9/30/2021	250,991	-4,804	4,098	4,753	N/A
6/30/2021	245,223	-4,494	3,299	3,982	N/A
3/31/2021	238,228	-4,538	3,901	4,542	N/A
12/31/2020	237,621	-4,189	5,231	5,826	N/A
9/30/2020	234,194	2,228	3,905	4,492	N/A
6/30/2020	231,002	922	2,851	3,363	N/A
3/31/2020	231,051	906	3,868	4,374	N/A
12/31/2019	224,945	-905	3,125	3,615	N/A
9/30/2019	221,981	-626	3,066	3,559	N/A
6/30/2019	217,440	601	4,523	5,046	N/A
3/31/2019	214,319	33	3,479	4,036	N/A
12/31/2018	213,518	-319	2,572	3,165	N/A
9/30/2018	210,927	113	2,751	3,324	N/A
6/30/2018	209,913	-384	1,936	2,543	N/A
3/31/2018	208,357	62	N/A	4,345	N/A
12/31/2017	205,442	4,805	N/A	2,756	N/A
9/30/2017	201,955	4,539	N/A	3,155	N/A
6/30/2017	199,851	4,846	N/A	3,626	N/A
3/31/2017	198,533	5,194	N/A	4,744	N/A
12/31/2016	196,498	2,051	N/A	6,415	N/A
9/30/2016	194,267	2,044	N/A	5,349	N/A
6/30/2016	193,071	2,359	N/A	5,077	N/A
3/31/2016	190,884	2,290	N/A	3,672	N/A
12/31/2015	189,131	2,237	N/A	2,449	N/A
9/30/2015	187,716	2,090	N/A	4,198	N/A
6/30/2015	183,115	1,950	N/A	3,384	N/A
3/31/2015	179,045	1,775	N/A	3,112	N/A
12/31/2014	171,952	1,780	N/A	3,893	N/A
9/30/2014	159,804	1,462	N/A	2,488	N/A
6/30/2014	148,629	1,402	N/A	2,602	N/A
3/31/2014	137,392	1,419	N/A	3,136	N/A
12/31/2013	130,076	1,278	N/A	2,679	N/A
9/30/2013	126,839	1,420	N/A	2,837	N/A

アナリストによる今後の成長予測

収入対貯蓄率: MCKの予測収益成長率 (年間9.6% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: MCKの収益 ( 9.6% ) US市場 ( 14.8% ) よりも低い成長が予測されています。

高成長収益: MCKの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: MCKの収益 ( 8.4% ) US市場 ( 8.5% ) よりも低い成長が予測されています。

高い収益成長: MCKの収益 ( 8.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: MCKの自己資本利益率は、3年後には非常に高くなると予測されています ( 208.5 %)。

McKesson 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Recent updates

McKesson Corporation to Report Q2, 2025 Results on Nov 06, 2024

McKesson: The Correction Is Not Over

CEO & Director notifies of intention to sell stock

Upcoming dividend of US$0.71 per share

McKesson Corporation (NYSE:MCK) Not Lagging Market On Growth Or Pricing

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

CEO & Director notifies of intention to sell stock

Fourth quarter dividend increased to US$0.71

McKesson Corporation Declares Regular Dividend on Common Stock, Payable on October 1, 2024

CEO & Director notifies of intention to sell stock

McKesson Corporation: An Interesting Health Giant With A Hidden Gem

McKesson Corporation to Report Q1, 2025 Results on Aug 07, 2024

McKesson Corporation, Annual General Meeting, Jul 31, 2024

Mckesson Corporation Elects Deborah Dunsire as New Director

Upcoming dividend of US$0.62 per share

Executive VP & CFO notifies of intention to sell stock

With McKesson Corporation (NYSE:MCK) It Looks Like You'll Get What You Pay For

Full year 2024 earnings: EPS exceeds analyst expectations

Third quarter dividend of US$0.62 announced

McKesson Corporation Declares Quarterly Dividend, Payable on June 3, 2024

McKesson Corporation to Report Q4, 2024 Results on May 07, 2024

CEO & Director notifies of intention to sell stock

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Upcoming dividend of US$0.62 per share

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter dividend of US$0.62 announced

High number of new directors

Mckesson Corporation Declares Quarterly Dividend, Payable on April 1, 2024

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

McKesson Corporation Reportedly Seeks Buyers for Canada's Rexall Pharmacy

McKesson Corporation (NYSE:MCK) acquired Compile, Inc.

Mckesson Corporation Elects Kevin Ozan as New Director

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q3, 2024 Results on Feb 07, 2024

McKesson Appoints Crystal Lennartz to Health Mart and Health Mart Atlas

Upcoming dividend of US$0.62 per share at 0.5% yield

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

CEO & Director notifies of intention to sell stock

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

McKesson Corporation Announces Management Changes

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson Corporation Declares Quarterly Dividend, Payable on January 2, 2024

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q2, 2024 Results on Nov 01, 2023

McKesson: Still Trading For A Huge Discount

Upcoming dividend of US$0.62 per share at 0.6% yield

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

CEO & Director notifies of intention to sell stock

CEO & Director notifies of intention to sell stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson Corporation Raises Quarterly Dividend, Payable on October 2, 2023

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q1, 2024 Results on Aug 02, 2023

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products

CEO & Director notifies of intention to sell stock

McKesson Corporation, Annual General Meeting, Jul 21, 2023

McKesson Corporation, Annual General Meeting, Jul 21, 2023

Executive VP exercised options and sold US$424k worth of stock

Upcoming dividend of US$0.54 per share at 0.5% yield

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

CEO & Director notifies of intention to sell stock

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Senior VP exercised options and sold US$88k worth of stock

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Upcoming dividend of US$0.54 per share at 0.6% yield

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

CEO & Director notifies of intention to sell stock